Resistance to arsenic trioxide and retinoic acid therapy in acute promyelocytic leukemia.
Department of Hematology, The Second Affiliated Hospital of Fujian Medical University, 34 Zhongshan North Road Quanzhou, Quanzhou, Fujian Province, 362000, China.
Xueya
X
Zhang
Department of Hematology, The Second Affiliated Hospital of Fujian Medical University, 34 Zhongshan North Road Quanzhou, Quanzhou, Fujian Province, 362000, China. zhangxy0212@sina.com.
Jingxin
J
Pan
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000008:administration & dosage*; D004252:DNA Mutational Analysis; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D017809:Fatal Outcome; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy* / Q000235:genetics*; D008297:Male; D020125:Mutation, Missense; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D010087:Oxides / Q000008:administration & dosage*; D014212:Tretinoin / Q000008:administration & dosage*
D001152:Arsenicals; D015514:Oncogene Proteins, Fusion; D010087:Oxides; C093476:promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein; D014212:Tretinoin; D000077237:Arsenic Trioxide